{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T21:08:20Z","timestamp":1769029700618,"version":"3.49.0"},"reference-count":14,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Cocaine Use Disorder (CUD), like all other stimulant use disorders, remains a challenging condition to treat, particularly in the absence of FDA-approved pharmacotherapies. While contingency management (CM) is considered first-line treatment and has demonstrated strong evidence for efficacy, it remains underutilized due to financial, philosophical, and logistical barriers. Off-label use of psychostimulants has emerged as a potential therapeutic strategy, especially in patients with comorbid attention-deficit\/hyperactivity disorder (ADHD). We present a case of a middle-aged male with a long-standing history of ADHD and recent onset of CUD, who experienced frequent relapses despite multiple rehabilitation efforts. Following reinstatement of dextroamphetamine-amphetamine salts, the patient demonstrated sustained abstinence from cocaine for six and a half months at the time of this paper\u2014his longest period of remission to date. His sobriety was supported by negative monthly urine drug screens and reduced cravings measured by the Cocaine Craving Scale (CCS). Current evidence supports CM and includes limited but growing support for stimulant substitution therapy. This case highlights the potential role of psychostimulants as a harm-reduction strategy in a carefully selected subset of patients with CUD and co-occurring ADHD. As stimulant use and overdose rates continue to rise, particularly with increasing adulteration by synthetic opioids, further research into effective, individualized treatments for stimulant use disorders, including CUD, is urgently needed.<\/jats:p>","DOI":"10.3389\/fpsyt.2026.1740412","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:40:42Z","timestamp":1768977642000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Using a controlled stimulant to treat cocaine use disorder in the setting of attention deficit\/hyperactivity disorder: a case study"],"prefix":"10.3389","volume":"17","author":[{"given":"Mack","family":"Bozman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent","family":"Collier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniket","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gray","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.9740\/MHC.2021.11.347","article-title":"Pharmacotherapy treatment of stimulant use disorder","volume":"11","author":"Liu","year":"2021","journal-title":"Ment Health Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093096","article-title":"Challenges of treating ADHD with comorbid substance use disorder: considerations for the clinician","volume":"12","author":"Barbuti","year":"2023","journal-title":"J Clin Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17103509","article-title":"Substance use disorder in adult-attention deficit hyperactive disorder patients: Patterns of use and related clinical features","volume":"17","author":"Spera","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234809","article-title":"Treatment of stimulant use disorder: A systematic review of reviews","volume":"15","author":"Ronsley","year":"2020","journal-title":"PloS One"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/jac.0000000000000450","article-title":"Contingency management for stimulant use disorder","volume":"46","author":"Rawson","year":"2023","journal-title":"J Ambulatory Care Manage"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.8049","article-title":"Comparison of treatments for cocaine use disorder among adults: A systematic review and meta-analysis","volume":"4","author":"Bentzley","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/inm.13144","article-title":"Prescription psychostimulants as a harm reduction and treatment intervention for methamphetamine use disorder and the implications for nursing clinical practice: A scoping review of the literature","volume":"32","author":"Leidl","year":"2023","journal-title":"Int J Ment Health Nurs"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2016.303627","article-title":"Recent increases in cocaine-related overdose deaths and the role of opioids","volume":"107","author":"Jones","year":"2017","journal-title":"Am J Public Health"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.1997.tb00401.x","article-title":"Early prediction of initiation of abstinence from cocaine: Use of a craving questionnaire","volume":"6","author":"Weiss","year":"1997","journal-title":"Am J Addict"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/ADM.0000000000001299","article-title":"The ASAM\/AAAP clinical practice guideline on the management of stimulant use disorder","volume":"18","year":"2024","journal-title":"J Addict Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/bf03391732","article-title":"Facilitating the adoption of contingency management for the treatment of substance use disorders","volume":"2","author":"Roll","year":"2009","journal-title":"Behav Anal Pract"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001110","article-title":"A mixed-methods evaluation of an addiction\/cardiology pilot clinic with contingency management for patients with stimulant-associated cardiomyopathy","volume":"17","author":"Leyde","year":"2023","journal-title":"J Addict Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/jamapsychiatry.2015.41","article-title":"Extended-release mixed amphetamine salts vs placebo for comorbid adult attention-deficit\/hyperactivity disorder and cocaine use disorder","volume":"72","author":"Levin","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd007380.pub3","article-title":"Efficacy of psychostimulant drugs for cocaine dependence","author":"Castells","year":"2010","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1740412\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:40:43Z","timestamp":1768977643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1740412\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":14,"alternative-id":["10.3389\/fpsyt.2026.1740412"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1740412","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"article-number":"1740412"}}